{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:05Z","timestamp":1792792265732,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"RJG Foundation"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2P30 NS047466"],"award-info":[{"award-number":["2P30 NS047466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NINDS","award":["P20 NS092530"],"award-info":[{"award-number":["P20 NS092530"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.expneurol.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T01:30:53Z","timestamp":1511141453000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":232,"special_numbering":"C","title":["Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-2812","authenticated-orcid":false,"given":"Ashley S.","family":"Harms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Thome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey M.","family":"Schonhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty N.","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-8348","authenticated-orcid":false,"given":"David G.","family":"Standaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.expneurol.2017.11.010_bb0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-140491","article-title":"Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease","volume":"5","author":"Allen Reish","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.expneurol.2017.11.010_bb0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/mds.25111","article-title":"Inflammation in Parkinson's disease: cause or consequence?","volume":"27","author":"Appel","year":"2012","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.expneurol.2017.11.010_bb0020","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2017.11.010_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0030","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.expneurol.2017.11.010_bb0035","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-beta-dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2017.11.010_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-5-42","article-title":"Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease","volume":"5","author":"Cao","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1742-2094-9-259","article-title":"The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia","volume":"9","author":"Cao","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2017.11.010_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(02)00170-4","article-title":"Induction of macrophage-derived chemokine\/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation","volume":"130","author":"Columba-Cabezas","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2017.11.010_bb0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.immunol.15.1.203","article-title":"Fc receptor biology","volume":"15","author":"Daeron","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.010_bb0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.192.6.899","article-title":"CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis","volume":"192","author":"Fife","year":"2000","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.010_bb0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.25300","article-title":"Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease","volume":"28","author":"Funk","year":"2013","journal-title":"Mov. Disord."},{"issue":"30","key":"10.1016\/j.expneurol.2017.11.010_bb0075","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.010_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)63805-9","article-title":"Experimental autoimmune encephalomyelitis (EAE) in CCR2(\u2212\/\u2212) mice: susceptibility in multiple strains","volume":"162","author":"Gaupp","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.expneurol.2017.11.010_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson's disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.expneurol.2017.11.010_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"issue":"23","key":"10.1016\/j.expneurol.2017.11.010_bb0100","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2017.11.010_bb0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2017.11.010_bb0110","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.010_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","article-title":"The genetics and neuropathology of Parkinson's disease","volume":"124","author":"Houlden","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.010_bb0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.192.7.1075","article-title":"Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2","volume":"192","author":"Izikson","year":"2000","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.expneurol.2017.11.010_bb0125","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.expneurol.2017.11.010_bb0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.010_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bpa.12371","article-title":"Neuroinflammation in Synucleinopathies","volume":"26","author":"Lim","year":"2016","journal-title":"Brain Pathol."},{"issue":"6109","key":"10.1016\/j.expneurol.2017.11.010_bb0140","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2017.11.010_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.expneurol.2017.11.010_bb0150","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1100421","article-title":"The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood","volume":"188","author":"Mizutani","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2017.11.010_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuroscience.2014.11.018","article-title":"M1 and M2 immune activation in Parkinson's Disease: foe and ally?","volume":"302","author":"Moehle","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.010_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2017.11.010_bb0170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.expneurol.2017.11.010_bb0175","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J. Neurosci."},{"issue":"Pt 11","key":"10.1016\/j.expneurol.2017.11.010_bb0180","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson's disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"issue":"3 Suppl 1","key":"10.1016\/j.expneurol.2017.11.010_bb0185","first-page":"S63","article-title":"Autosomal dominant Parkinson's disease and alpha-synuclein","volume":"44","author":"Polymeropoulos","year":"1998","journal-title":"Ann. Neurol."},{"issue":"5321","key":"10.1016\/j.expneurol.2017.11.010_bb0190","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.010_bb0195","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.2923","article-title":"Heterogeneity of CNS myeloid cells and their roles in neurodegeneration","volume":"14","author":"Prinz","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"13","key":"10.1016\/j.expneurol.2017.11.010_bb0200","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1073\/pnas.1117218109","article-title":"Signal transducer and activator of transcription-3\/suppressor of cytokine signaling-3 (STAT3\/SOCS3) axis in myeloid cells regulates neuroinflammation","volume":"109","author":"Qin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6183","key":"10.1016\/j.expneurol.2017.11.010_bb0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.1249547","article-title":"Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes","volume":"344","author":"Raj","year":"2014","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.expneurol.2017.11.010_bb0210","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/nn.2917","article-title":"Microglia and monocytes: 'tis plain the twain meet in the brain","volume":"14","author":"Ransohoff","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"7321","key":"10.1016\/j.expneurol.2017.11.010_bb0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature09615","article-title":"The myeloid cells of the central nervous system parenchyma","volume":"468","author":"Ransohoff","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson's disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.010_bb0225","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.expneurol.2017.11.010_bb0230","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.010_bb0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013693","article-title":"Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice","volume":"5","author":"Saederup","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.expneurol.2017.11.010_bb0245","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.expneurol.2017.11.010_bb0255","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson's disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2017.11.010_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.2009.05984.x","article-title":"Differential gene expression in LPS\/IFNgamma activated microglia and macrophages: in vitro versus in vivo","volume":"109","author":"Schmid","year":"2009","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.expneurol.2017.11.010_bb0265","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"issue":"7601","key":"10.1016\/j.expneurol.2017.11.010_bb0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature17939","article-title":"Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression","volume":"533","author":"Soldner","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2017.11.010_bb0275","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.expneurol.2017.11.010_bb0280","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2017.11.010_bb0285","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2017.11.010_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140566","article-title":"Fractalkine signaling regulates the inflammatory response in an alpha-Synuclein model of Parkinson disease","volume":"10","author":"Thome","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.expneurol.2017.11.010_bb0295","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-Synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2017.11.010_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"Supplemental 1","key":"10.1016\/j.expneurol.2017.11.010_bb0305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.13627","article-title":"How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson disease?","volume":"139","author":"Volpicelli-Daley","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.11.010_bb0310","series-title":"Regionally Specific Microglial Activation Precedes Neuropathology and Peripheral Immune Response in Mice Over-Expressing Wildtype Alpha Synuclein","volume":"2011","author":"Watson","year":"2011"},{"issue":"2","key":"10.1016\/j.expneurol.2017.11.010_bb0315","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2017.11.010_bb0320","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.expneurol.2017.11.010_bb0325","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J. Exp. Med."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617303229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617303229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:48:39Z","timestamp":1762148919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617303229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":65,"alternative-id":["S0014488617303229"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}